Guidelines Adherence and Hypertension Control in an Outpatient Cardiology Clinic in Malaysia
Purpose: To evaluate doctors’ adherence to Malaysian Clinical Practice Guideline (CPG) 2008 in established hypertensive patients with cardiovascular diseases and factors associated with guideline adherence and hypertension control in Pulau Pinang Hospital, Malaysia. Methods: Prescriptions written by 13 doctors for 320 established hypertensive patients with cardiovascular diseases (25 patients per doctor) were noted on first visit. Two hundred and sixty (81%) of the enrolled 320 patients (20 patients per doctor) were followed up until the second visit. Blood pressure (BP) noted on the second visit was related to the prescription written on the first visit. Results: One hundred and ninety one (73.5%) patients received guidelines-compliant pharmacotherapy. CPG adherence had statistically significant association with left ventricular hypertrophy (LVH) (Ф =-0.241, p < 0.01) and diabetes (Ф =-0.228, p < 0.01). One hundred and fifty four (59.2 %) patients were on goal BP. Hypertension control had statistically significant association with guidelines compliance (Ф = 0.175, p < 0.01), angiotensin converting enzyme (ACE) inhibitors (Ф = 0.195, p < 0.01), diabetes (Ф = -0.148, p = 0.017), LVH (Ф = -0.153, p = 0.017) and monotherapy (Ф = - 0.168, p < 0.01). Conclusion: Prescribing practices were fairly compliant with guidelines. Doctors poorly adhered to guidelines in hypertensive patients with diabetes and LVH. Significantly better hypertension control was seen in patients who were on ACE inhibitors and guidelines-adherent therapy.
Keywords: Guidelines, Adherence, Hypertension control, Diabetes, Cardiology
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.